These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7645524)

  • 1. Trimetazidine effects on the damage to mitochondrial functions caused by ischemia and reperfusion.
    Veitch K; Maisin L; Hue L
    Am J Cardiol; 1995 Aug; 76(6):25B-30B. PubMed ID: 7645524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium.
    Guarnieri C; Muscari C
    Pharmacology; 1993 Jun; 46(6):324-31. PubMed ID: 8516381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M; Dernek S; Sevin B; Kural T
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
    Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts.
    Boucher FR; Hearse DJ; Opie LH
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):45-9. PubMed ID: 7521488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
    Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
    Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimetazidine: in vitro influence on heart mitochondrial function.
    Demaison L; Fantini E; Sentex E; Grynberg A; Athias P
    Am J Cardiol; 1995 Aug; 76(6):31B-37B. PubMed ID: 7645525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts.
    Gambert S; Vergely C; Filomenko R; Moreau D; Bettaieb A; Opie LH; Rochette L
    Mol Cell Biochem; 2006 Feb; 283(1-2):147-52. PubMed ID: 16444597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
    Kantor PF; Lucien A; Kozak R; Lopaschuk GD
    Circ Res; 2000 Mar; 86(5):580-8. PubMed ID: 10720420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia.
    El Banani H; Bernard M; Baetz D; Cabanes E; Cozzone P; Lucien A; Feuvray D
    Cardiovasc Res; 2000 Sep; 47(4):688-96. PubMed ID: 10974217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
    Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
    Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinate accumulation impairs cardiac pyruvate dehydrogenase activity through GRP91-dependent and independent signaling pathways: Therapeutic effects of ginsenoside Rb1.
    Li J; Yang YL; Li LZ; Zhang L; Liu Q; Liu K; Li P; Liu B; Qi LW
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2835-2847. PubMed ID: 28736181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia.
    Monteiro P; Duarte AI; Gonçalves LM; Moreno A; Providência LA
    Eur J Pharmacol; 2004 Oct; 503(1-3):123-8. PubMed ID: 15496306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of long-term preservation of the isolated arrested rat heart by trimetazidine: effects on the energy state and mitochondrial function.
    Kay L; Finelli C; Aussedat J; Guarnieri C; Rossi A
    Am J Cardiol; 1995 Aug; 76(6):45B-49B. PubMed ID: 7645529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury.
    Şentürk T; Çavun S; Avcı B; Yermezler A; Serdar Z; Savcı V
    Atherosclerosis; 2014 Dec; 237(2):760-6. PubMed ID: 25463117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimetazidine prevents palmitate-induced mitochondrial fission and dysfunction in cultured cardiomyocytes.
    Kuzmicic J; Parra V; Verdejo HE; López-Crisosto C; Chiong M; García L; Jensen MD; Bernlohr DA; Castro PF; Lavandero S
    Biochem Pharmacol; 2014 Oct; 91(3):323-36. PubMed ID: 25091560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat cardiac mitochondrial sub-populations show distinct features of oxidative phosphorylation during ischemia, reperfusion and ischemic preconditioning.
    Kurian GA; Berenshtein E; Saada A; Chevion M
    Cell Physiol Biochem; 2012; 30(1):83-94. PubMed ID: 22759958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetramethylphenylenediamine protects the isolated heart against ischaemia-induced apoptosis and reperfusion-induced necrosis.
    Barauskaite J; Grybauskiene R; Morkuniene R; Borutaite V; Brown GC
    Br J Pharmacol; 2011 Mar; 162(5):1136-42. PubMed ID: 21077848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion.
    Chen Q; Moghaddas S; Hoppel CL; Lesnefsky EJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1405-12. PubMed ID: 16990510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury.
    Argaud L; Gomez L; Gateau-Roesch O; Couture-Lepetit E; Loufouat J; Robert D; Ovize M
    J Mol Cell Cardiol; 2005 Dec; 39(6):893-9. PubMed ID: 16243351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.